Immunotherapy in Advanced Gastric Cancer: An Overview of the Emerging Strategies

Gastric cancer (GC) remains a public health problem, being the fifth most common cancer worldwide. In the western countries, the majority of patients present with advanced disease. Additionally, 65 to 75% of patients treated with curative intent will relapse and develop systemic disease. In metastat...

Descripción completa

Detalles Bibliográficos
Autores principales: Magalhães, Helena, Fontes-Sousa, Mário, Machado, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031212/
https://www.ncbi.nlm.nih.gov/pubmed/30027089
http://dx.doi.org/10.1155/2018/2732408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031212/
https://www.ncbi.nlm.nih.gov/pubmed/30027089
http://dx.doi.org/10.1155/2018/2732408

Ejemplares similares